Alzamend Neuro, Inc. (ALZN)
NASDAQ·Healthcare·Biotechnology
$1.09
+0.93%
Mkt Cap $6.84M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 11, 2026 | — | — | — | -$0.53 | -$0.58 | -9.43% | — | — |
| Q4 2025 Dec 9, 2025 | — | — | — | -$0.83 | -$0.30 | +63.86% | — | — |
| Q3 2025 Sep 10, 2025 | — | — | — | -$3.69 | -$1.28 | +65.31% | — | — |
| Q1 2025 Mar 10, 2025 | — | — | — | -$2.61 | -$1.71 | +34.48% | — | — |
| Q4 2024 Dec 11, 2024 | — | — | — | -$21.42 | -$3.60 | +83.19% | — | — |
| Q3 2024 Sep 11, 2024 | — | — | — | -$2.38 | -$11.25 | -372.69% | — | — |
| Q3 2024 Jul 30, 2024 | — | $76.11K | — | -$2.75 | -$13.35 | -385.45% | — | — |
| Q1 2024 Mar 25, 2024 | — | — | — | -$0.32 | -$34.20 | -10587.50% | — | — |
| Q4 2023 Dec 15, 2023 | — | — | — | -$0.67 | $39.60 | +6010.45% | — | — |
| Q3 2023 Sep 13, 2023 | — | — | — | -$47.23 | -$53.98 | -14.29% | — | — |
| Q3 2023 Jul 27, 2023 | — | — | — | -$30.36 | -$40.48 | -33.33% | — | — |
| Q1 2023 Mar 15, 2023 | — | — | — | -$0.04 | -$0.06 | -50.00% | — | — |
| Q4 2022 Dec 12, 2022 | — | — | — | -$0.02 | -$0.03 | -25.00% | — | — |
| Q3 2022 Sep 13, 2022 | — | — | — | -$0.07 | -$0.03 | +57.14% | — | — |
| Q3 2022 Jul 19, 2022 | — | — | — | -$0.03 | -$0.04 | -33.33% | — | — |
| Q1 2022 Mar 15, 2022 | — | — | — | -$0.02 | -$0.03 | -50.00% | — | — |
| Q4 2021 Dec 13, 2021 | — | — | — | -$0.03 | -$0.04 | -60.00% | — | — |
| Q3 2021 Sep 13, 2021 | — | — | — | — | -$0.84 | — | — | — |
| Q3 2021 Jul 29, 2021 | — | — | — | — | -$0.51 | — | — | — |
| Q1 2021 Jan 31, 2021 | — | — | — | — | -$0.46 | — | — | — |